Literature DB >> 24189904

Cortical effects of deep brain stimulation: implications for pathogenesis and treatment of Parkinson disease.

Qian Li1, Zhong-Ming Qian2, Gordon W Arbuthnott3, Ya Ke1, Wing-Ho Yung1.   

Abstract

High-frequency electrical stimulation that targets the subthalamic nucleus has proved to be beneficial in alleviating the motor symptoms in many patients with Parkinson disease. The mechanism of action for this paradigm of deep brain stimulation is still not fully understood, and this is, in part, attributed to the fact that there are diverse cellular elements at the stimulation site that could bring about local and distal effects. Recent studies in both human and animal models strongly suggest that the activity in the cortex, especially in the motor cortical areas, is directly altered by deep brain stimulation by signals traveling in an antidromic fashion from the subthalamic nucleus. Herein, we discuss the evidence for this proposition, as well as the mechanism by which antidromic activation desynchronizes motor cortical activity. The implications of these new findings for the pathogenesis and treatment of Parkinson disease are highlighted.

Entities:  

Mesh:

Year:  2014        PMID: 24189904     DOI: 10.1001/jamaneurol.2013.4221

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  20 in total

1.  Tractography patterns of subthalamic nucleus deep brain stimulation.

Authors:  Nora Vanegas-Arroyave; Peter M Lauro; Ling Huang; Mark Hallett; Silvina G Horovitz; Kareem A Zaghloul; Codrin Lungu
Journal:  Brain       Date:  2016-02-26       Impact factor: 13.501

2.  Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation.

Authors:  Luke A Johnson; Jing Wang; Shane D Nebeck; Jianyu Zhang; Matthew D Johnson; Jerrold L Vitek
Journal:  J Neurosci       Date:  2020-02-04       Impact factor: 6.167

3.  Optogenetic Stimulation of the M2 Cortex Reverts Motor Dysfunction in a Mouse Model of Parkinson's Disease.

Authors:  Luiz Alexandre Viana Magno; Helia Tenza-Ferrer; Mélcar Collodetti; Matheus Felipe Guimarães Aguiar; Ana Paula Carneiro Rodrigues; Rodrigo Souza da Silva; Joice do Prado Silva; Nycolle Ferreira Nicolau; Daniela Valadão Freitas Rosa; Alexander Birbrair; Débora Marques Miranda; Marco Aurélio Romano-Silva
Journal:  J Neurosci       Date:  2019-02-19       Impact factor: 6.167

Review 4.  Targeting the neurophysiology of cognitive systems with transcranial alternating current stimulation.

Authors:  Flavio Fröhlich; Kristin K Sellers; Asa L Cordle
Journal:  Expert Rev Neurother       Date:  2014-12-30       Impact factor: 4.618

5.  The cortical evoked potential corresponds with deep brain stimulation efficacy in rats.

Authors:  Isaac R Cassar; Warren M Grill
Journal:  J Neurophysiol       Date:  2022-04-07       Impact factor: 2.974

Review 6.  Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

Authors:  Dhanya Vijayakumar; Joseph Jankovic
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

7.  Action potential initiation, propagation, and cortical invasion in the hyperdirect pathway during subthalamic deep brain stimulation.

Authors:  Ross W Anderson; AmirAli Farokhniaee; Kabilar Gunalan; Bryan Howell; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2018-05-12       Impact factor: 8.955

8.  Biophysical reconstruction of the signal conduction underlying short-latency cortical evoked potentials generated by subthalamic deep brain stimulation.

Authors:  Kabilar Gunalan; Cameron C McIntyre
Journal:  Clin Neurophysiol       Date:  2019-11-05       Impact factor: 3.708

Review 9.  Deep brain stimulation for movement disorders.

Authors:  Paul S Larson
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

10.  Model-based deconstruction of cortical evoked potentials generated by subthalamic nucleus deep brain stimulation.

Authors:  Karthik Kumaravelu; Chintan S Oza; Christina E Behrend; Warren M Grill
Journal:  J Neurophysiol       Date:  2018-04-25       Impact factor: 2.974

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.